Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Balance Sheets

v3.22.2.2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Jun. 30, 2022
Current assets:    
Cash and cash equivalents $ 154,322 $ 150,410
Prepaid expenses and other 1,305 1,694
Total current assets 155,627 152,104
Deposits and other 148 148
Right-of-use assets 130 152
Property and equipment, net 83 16
Total assets 155,988 152,420
Current liabilities:    
Accounts payable 1,110 1,132
Accrued liabilities:    
Insurance premiums 122 243
Accrued clinical and other 1,085 979
Current portion of operating lease liabilities 112 108
Total current liabilities 2,429 2,462
Long term liabilities:    
Operating lease liabilities, net of current portion 49 80
Embedded derivative liabilities 420 407
Total liabilities 2,898 2,949
Commitments and contingencies (Notes 3, 4, 8 and 9)
Shareholders' equity:    
Preferred stock, $0.001 par value; 400 shares authorized; no shares issued and outstanding
Common stock, $0.001 par value; 100,000 shares authorized; issued and outstanding 36,827 and 33,582 shares as of September 30, 2022 and June 30, 2022, respectively 37 34
Additional paid-in capital 372,082 358,635
Accumulated deficit (219,029) (209,198)
Total shareholders' equity 153,090 149,471
Total liabilities and shareholders' equity $ 155,988 $ 152,420